Sunday, September 27, 2026

Pharma Partnerships

1 article

NVIDIA Infrastructure Deals With Thermo Fisher, Lilly Anchor Pharma's Shift to AI-Native Drug Discovery

NVIDIA is expanding as an infrastructure provider to Thermo Fisher and Eli Lilly as a cluster of AI-native biotech platforms launches in 2026. Novo Nordisk posted strong Q1 2026 results while closing its internal cell therapy unit and licensing the asset to AI-native platform Cellular Intelligence, signaling top pharma is outsourcing discovery capability rather than building it in-house.

LM Salvado•Aug 8, 2026

What we know · the intelligence behind this page

Live from the substrate

What we're seeing

Vertical AI Agents Attract a Funding Wave Across Fintech-Adjacent Industries

A cluster of AI-native startups applying autonomous agents to narrow, operational problems — hotel front-desk staffing (Dextr AI), identity/fraud risk for financial institutions (Baselayer), insurance distribution (Napo, Connie Health, MGT Insurance) — closed seed-to-Series A rounds within days of each other in September 2026, with CB Insights running a coordinated CEO interview series to spotlight them. The pattern points to agentic AI maturing from generic chat tools into vertical, revenue-generating products, with identity verification for AI agents themselves (Baselayer) emerging as a new fintech infrastructure category responding directly to AI-driven fraud risk.

Our read on the data ›

Signals we're tracking

Satellite-Terrestrial Network Integration Acceleration

Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases

Patterns we're watching ›

Where sources disagree

ING Group

Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.

We flag conflicts openly ›

Recently verified

✓ Checked against the original source

4,984

facts traced to their source — and we flag the ones that don't hold up.

101 entities tracked4,984 facts checked against source5,306 source documents archived

Query this data → isubstrate.com